Anti-angiogenic ophthalmic agents

Lucentis 0.3 mg/0.05 mL (6 mg/mL) injection Images

Generic Name: ranibizumab

This medication has been identified as Lucentis 0.3 mg/0.05 mL (6 mg/mL) injection. It is supplied by Genentech, Inc.

Lucentis is used in the treatment of Macular Degeneration; Diabetic Macular Edema; Macular Edema; Myopic Choroidal Neovascularization; Diabetic Retinopathy and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Lucentis 0.3 mg/0.05 mL (6 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Lucentis (Ranibizumab (ophthalmic) [ ra-nib-i-zue-mab-off-thal-mik ])-medicine-0.3 mg/0.05 mL (6 mg/mL) injection

Lucentis
Generic Name: ranibizumab (ophthalmic) [ ra-nib-i-zue-mab-off-thal-mik ]
Imprint: medicine
Strength: 0.3 mg/0.05 mL (6 mg/mL) injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Anti-angiogenic ophthalmic agents
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 50242-0082
Inactive Ingredients:
Latest News
Related Drugs